Hims & Hers Health (HIMS) Q1 swung to a loss of $0.40 per diluted share late Monday, from an earnings of $0.20 a year ago.

Analysts polled by FactSet expected EPS of $0.03.

Revenue for the three months ended March 31 rose to $608.1 million from $586.0 million a year earlier.

Analysts surveyed by FactSet expected $616.8 million.

The company expects Q2 revenue of $680 million to $700 million. Analysts expect $643.0 million.

The firm expects 2026 revenue of $2.8 billion to $3.0 billion, up from $2.7 billion to $2.9 billion. Analysts expect $2.75 billion.